BREAST CANCER BASE

Treatment of breast cancer often choose which chemotherapy? Almost all anti-cancer drugs in cell division play a role. As normal cells as cell division frequent, less susceptible to anti-cancer drugs...

What is systemic chemotherapy and local chemotherapy The so-called systemic chemotherapy, and chemotherapy is limited ways and means of delivery and after administration of different drugs in v...

Recently in Beijing at the 2003 new breast cancer treatment at the seminar, from the United States BaylorSammons breast cancer experts in the center released by the Center for metastatic breast cancer in combination with chemotherapy in patients with the latest research findings.

The study of 529 untreated metastatic breast cancer patients, before the transfer have received anthracycline-based drug treatment. The study will be divided into two groups in all cases, a group of 267 patients who received Gemzar / Taxol combination with chemotherapy for a 21-day cycle; The remaining patients to accept another group of single-drug paclitaxel chemotherapy, treatment continued until disease progression or the emergence of tolerance of side effects. The results showed that combination chemotherapy group that the median time to progression was 5.4 months, Taxol alone group to 3.5 months. In addition, the United chemotherapy group over 50% of patients without disease progression time is six months.

Studies show that the two groups of non-hematologic toxicity were lighter, Ⅳ hematological toxicity seen more chemotherapy group. The two most common side effects of the tablets which cells or leukocytes reduced incidence of 17.2% and 6.6%. Experts believe that the United States, although some showed signs of combination chemotherapy drugs may be better than separate, but such studies have not been more recent combination with a separate drug study survival data, therefore, should be combined with chemotherapy or to care for the treatment of metastatic breast cancer patients were selected cases.

A new biological scanner to early detection of breast cancer NASA Development Authority of biological scanner has been found to the right of women to successfully breast cancer early diagnosis, so tha...

Breast cancer can also prevent The general view has been dubbed "the first lady killer" of breast cancer is not only anti-administration with him. But with the ...

The U.S. Food and Drug Administration approved paclitaxel for the treatment of early breast cancer     由于该管理局咨询委员会全体成员的一致推荐，今年九月份，美国食品与药物管理局批准，在阿霉素�...

Obese breast cancer patients need chemotherapy dose reduction The obesity to breast cancer chemotherapy patients, clinicians account of the distribution and drug toxicity, it is usually to reduce the do...

New progress in breast cancer chemotherapy Female breast cancer is the most common malignancy in the world context, the incidence of breast cancer is rising year on year. Epidemiologi...

Chemotherapy for Breast Cancer What role Chemotherapy is the role of cytotoxic drug eradication Yat into the bloodstream and lymphatic system cancer, when the transfer occurred and...

Application of breast cancer after Femara for endocrine therapy?

Femara clinical research process active endocrine therapy for breast cancer